Showing results (21-30 of 5,789) with videos related to
Sort By:
Pageof 579
British Journal of Cancer|February 25, 2009
Phase I study of epirubicin, cisplatin and capecitabine plus matuzumab in previously untreated patients with advanced oesophagogastric cancerS Rao, N Starling, D Cunningham, et al.British Journal of Cancer|July 22, 2004
Phase II study of capecitabine and mitomycin C as first-line treatment in patients with advanced colorectal cancerS Rao, D Cunningham, T Price, et al.British Heart Journal|January 1, 1992
Impact of catheter and surgical ablation on arrhythmia treatment in a tertiary referral centreD Cunningham, E RowlandSeminars in Oncology|April 23, 1999
A phase III study of irinotecan (CPT-11) versus best supportive care in patients with metastatic colorectal cancer who have failed 5-fluorouracil therapy. V301 Study GroupD Cunningham, B GlimeliusAnnals of Oncology : Official Journal of the European Society for Medical Oncology|March 10, 2006
Adjuvant therapy in colon cancer--what, when and how?I Chau, D CunninghamCancer Treatment Reviews|September 8, 2001
New options for outpatient chemotherapy--the role of oral fluoropyrimidinesD Cunningham, R ColemanStudies in Health Technology and Informatics|October 28, 1999
Virtual reality: a wholistic approach to rehabilitationD Cunningham, M KrishackThe British Journal of Surgery|November 21, 2012
Impact of targeted neoadjuvant therapies in the treatment of solid organ tumoursT Waddell, D CunninghamEuropean Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|June 1, 2005
Gastrointestinal cancer: recent developments in medical oncologyG Chong, D CunninghamBritish Journal of Cancer|January 1, 1990
Dexamethasone can potentiate the anti-emetic action of a 5HT3 receptor antagonist on cyclophosphamide induced vomiting in the ferretJ Hawthorn, D CunninghamPageof 579